FLT3 and acute myeloid leukemia: Of notice, dual FLT3/JAK2 inhibitor pacritinib (SB1518; Figure 5) [66] strongly inhibits FLT3 auto-phosphorylation and its downstream signaling pathways in AML cell lines and has efficacy in FLT3-ITD driven AML murine xenograft models [67].